Cargando…

A Web Tool to Estimate Baseline Anti-Spike Monoclonal Antibody Efficacy Based on Regional Genomic Surveillance

Drug appropriateness is a pillar of modern evidence-based medicine, but the turnaround times of genomic sequencing are not compatible with the urgent need to deliver treatments against microorganisms. Massive worldwide genomic surveillance has created an unprecedented landscape for exploiting viral...

Descripción completa

Detalles Bibliográficos
Autor principal:	Focosi, Daniele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224003/ https://www.ncbi.nlm.nih.gov/pubmed/37243134 http://dx.doi.org/10.3390/v15051048

Ejemplares similares

The Omicron variant of concern: Diversification and convergent evolution in spike protein, and escape from anti-Spike monoclonal antibodies
por: Focosi, Daniele, et al.
Publicado: (2022)

Prescription of Anti-Spike Monoclonal Antibodies in COVID-19 Patients with Resistant SARS-CoV-2 Variants in Italy
por: Focosi, Daniele, et al.
Publicado: (2022)

Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline
por: Tuccori, Marco, et al.
Publicado: (2020)

SARS-CoV-2 Variants: A Synopsis of In Vitro Efficacy Data of Convalescent Plasma, Currently Marketed Vaccines, and Monoclonal Antibodies
por: Focosi, Daniele, et al.
Publicado: (2021)

A Critical Analysis of the Use of Cilgavimab plus Tixagevimab Monoclonal Antibody Cocktail (Evusheld™) for COVID-19 Prophylaxis and Treatment
por: Focosi, Daniele, et al.
Publicado: (2022)

SARS-CoV-2 variants resistant to monoclonal antibodies in immunocompromised patients constitute a public health concern
por: Casadevall, Arturo, et al.
Publicado: (2023)

On the Need to Determine the Contribution of Anti-Nucleocapsid Antibodies as Potential Contributors to COVID-19 Convalescent Plasma Efficacy
por: Focosi, Daniele, et al.
Publicado: (2022)

Qualitative immunoassay for the detection of anti-SARS-COV-2 spike antibody in human milk samples
por: Yang, Xiaoqi, et al.
Publicado: (2022)

Monoclonal antibody therapies against SARS-CoV-2
por: Focosi, Daniele, et al.
Publicado: (2022)

A flow cytometry-based assay for serological detection of anti-spike antibodies in COVID-19 patients
por: Goh, Yun Shan, et al.
Publicado: (2021)

Comprehensive evaluation of peptide de novo sequencing tools for monoclonal antibody assembly
por: Beslic, Denis, et al.
Publicado: (2022)

Protocol for production and expression of chimeric bovine-human monoclonal antibodies
por: Heydarchi, Behnaz, et al.
Publicado: (2022)

39. Anti-Spike Monoclonal Antibody Therapy for Kidney Transplant Recipients with COVID-19
por: Hardesty, Anna, et al.
Publicado: (2021)

Patient Perspectives on Anti-spike Monoclonal Antibody Therapy for Mild to Moderate Coronavirus Disease-2019
por: Razonable, Raymund R, et al.
Publicado: (2022)

Monoclonal antibody therapy for Kawasaki disease: a protocol for systematic reviews and meta-analysis
por: Nomura, Osamu, et al.
Publicado: (2016)

Do We Really Need Omicron Spike-Based Updated COVID-19 Vaccines? Evidence and Pipeline
por: Focosi, Daniele, et al.
Publicado: (2022)

The Safety and Efficacy of Calcitonin Gene-Related Peptide (CGRP) Monoclonal Antibodies for the Preventive Treatment of Migraine: A Protocol for Multiple-Treatment Systematic Review and Meta-Analysis
por: Fernández-Bravo-Rodrigo, Jaime, et al.
Publicado: (2022)

From Surveillance to Intervention: Overview and Baseline Findings for the Active City of Liverpool Active Schools and SportsLinx (A-CLASS) Project
por: McWhannell, Nicola, et al.
Publicado: (2018)

Genomic surveillance of SARS-CoV-2 Spike gene by sanger sequencing
por: Salles, Tiago Souza, et al.
Publicado: (2022)

Production and purification of recombinant monoclonal antibodies from human cells based on a primary sequence
por: DeLuca, Keith F., et al.
Publicado: (2022)

Safety, tolerability, and efficacy of monoclonal CD38 antibody felzartamab in late antibody-mediated renal allograft rejection: study protocol for a phase 2 trial
por: Mayer, Katharina A., et al.
Publicado: (2022)

Monoclonal Anti-AMP Antibodies Are Sensitive and Valuable Tools for Detecting Patterns of AMPylation
por: Höpfner, Dorothea, et al.
Publicado: (2020)

Monoclonal Anti-AMP Antibodies Are Sensitive and Valuable Tools for Detecting Patterns of AMPylation
por: Höpfner, Dorothea, et al.
Publicado: (2021)

Monoclonal antibody targeting the conserved region of the SARS-CoV-2 spike protein to overcome viral variants
por: Wu, Wan-Ling, et al.
Publicado: (2022)

Sequencing, cloning, and antigen binding analysis of monoclonal antibodies isolated from single mouse B cells
por: Viant, Charlotte, et al.
Publicado: (2021)

Characterization of novel monoclonal antibodies against MERS-coronavirus spike protein
por: Goo, Junghyun, et al.
Publicado: (2020)

First Case of COVID-19 Treated with Monoclonal Anti-Spike Antibodies in a Patient with Cystic Fibrosis in Romania
por: Stan, Iustina Violeta, et al.
Publicado: (2022)

Anti-Spike Monoclonal Antibody Therapy in Pregnant Women With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)
por: Thilagar, Bright P., et al.
Publicado: (2022)

Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody
por: Phan, Tin, et al.
Publicado: (2023)

Successful use of casirivimab/imdevimab anti-spike monoclonal antibodies to enhance neutralizing antibodies in a woman on anti-CD20 treatment with refractory COVID-19
por: Miyazato, Yusuke, et al.
Publicado: (2022)

In vitro and in vivo anticancer efficacy of unconjugated humanised anti-CEA monoclonal antibodies
por: Blumenthal, R D, et al.
Publicado: (2008)

Improving the efficacy of plant-made anti-HIV monoclonal antibodies for clinical use
por: Grandits, Melanie, et al.
Publicado: (2023)

Establishment of anti-mesothelioma monoclonal antibodies
por: Mizutani, Natsuko, et al.
Publicado: (2016)

Standardized immunoprecipitation protocol for efficient isolation of native apolipoprotein E particles utilizing HJ15.4 monoclonal antibody
por: O’Leary, Justin, et al.
Publicado: (2023)

Monoclonal Antibodies as Tools to Combat Fungal Infections
por: Ulrich, Sebastian, et al.
Publicado: (2020)

Outpatient anti-spike monoclonal antibody administration is associated with decreased morbidity and mortality among patients with cancer and COVID-19
por: Arvanitis, Panos, et al.
Publicado: (2023)

Outpatient anti-spike monoclonal antibody administration is associated with decreased morbidity and mortality among patients with cancer and COVID-19
por: Arvanitis, Panos, et al.
Publicado: (2023)

Concentrating white spot syndrome virus by alum for field detection using a monoclonal antibody based flow-through assay
por: Rani, Amrita, et al.
Publicado: (2016)

A Tailored Web-based Advice Tool for Skiers and Snowboarders: Protocol for a Randomized Controlled Trial
por: Kemler, Ellen, et al.
Publicado: (2018)

The DANTE trial protocol: a randomised phase III trial to evaluate the Duration of ANti-PD-1 monoclonal antibody Treatment in patients with metastatic mElanoma
por: Coen, Oliver, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ior1navsn6n5tb9tucu4s4bk50